Serological Diagnosis of Human Herpes Simplex Virus Type 1 and 2 Infections by Luciferase Immunoprecipitation System Assay | Clinical and Vaccine Immunology
Infectious Disease Reports | Free Full-Text | Diagnosis of Herpes Simplex Virus: Laboratory and Point-of-Care Techniques | HTML
Human Anti-Herpes simplex virus Type 1 and 2 IgG ELISA Kit (HSV1+2) (ab108741)
A novel bioluminescent herpes simplex virus 1 for in vivo monitoring of herpes simplex encephalitis | Scientific Reports
Immune responses to a HSV-2 polynucleotide immunotherapy COR-1 in HSV-2 positive subjects: A randomized double blinded phase I/IIa trial | PLOS ONE
A Live-Attenuated HSV-2 ICP0− Virus Elicits 10 to 100 Times Greater Protection against Genital Herpes than a Glycoprotein D Subunit Vaccine | PLOS ONE
Is HSV serology useful for the management of first episode genital herpes? | Sexually Transmitted Infections
Vaccines | Free Full-Text | Immune Response to Herpes Simplex Virus Infection and Vaccine Development | HTML
Highly Effective and Safe Polymeric Inhibitors of Herpes Simplex Virus in Vitro and in Vivo | ACS Applied Materials & Interfaces
Frontiers | Herpes Simplex Virus Type 1 Infection of the Central Nervous System: Insights Into Proposed Interrelationships With Neurodegenerative Disorders
Frontiers | A Novel Method to Titrate Herpes Simplex Virus-1 (HSV-1) Using Laser-Based Scanning of Near-Infrared Fluorophores Conjugated Antibodies
HSV Peptide (H4640) - Datasheet
Current Concepts for Genital Herpes Simplex Virus Infection: Diagnostics and Pathogenesis of Genital Tract Shedding | Clinical Microbiology Reviews
Serological Diagnosis of Human Herpes Simplex Virus Type 1 and 2 Infections by Luciferase Immunoprecipitation System Assay | Clinical and Vaccine Immunology
Immune characteristics correlating with HSV‐1 immune control and effect of squaric acid dibutyl ester on immune characteristics of subjects with frequent herpes labialis episodes - McTavish - 2019 - Immunity, Inflammation and
Infectious Disease Reports | Free Full-Text | Diagnosis of Herpes Simplex Virus: Laboratory and Point-of-Care Techniques | HTML
Long-term time trends in reactivated herpes simplex infections and treatment in Sweden | BMC Infectious Diseases | Full Text
Frontiers | Cepharanthine Suppresses Herpes Simplex Virus Type 1 Replication Through the Downregulation of the PI3K/Akt and p38 MAPK Signaling Pathways
Non-cytopathic herpes simplex virus type-1 isolated from acyclovir-treated patients with recurrent infections | Scientific Reports
HSV-1 gD Antibody (DL6) | SCBT - Santa Cruz Biotechnology
Herpes Simplex Virus I (HSV)-IgG Test : Results, risks, procedure - FactDr
JCI - Trivalent nucleoside-modified mRNA vaccine yields durable memory B cell protection against genital herpes in preclinical models
Immune characteristics correlating with HSV‐1 immune control and effect of squaric acid dibutyl ester on immune characteristics of subjects with frequent herpes labialis episodes - McTavish - 2019 - Immunity, Inflammation and
Herpes Simplex Virus (HSV) IgM Antibody Testing Update – Spectrum Health Labs
Design of an Interferon-Resistant Oncolytic HSV-1 Incorporating Redundant Safety Modalities for Improved Tolerability: Molecular Therapy - Oncolytics
Identification of a herpes simplex virus 1 gene encoding neurovirulence factor by chemical proteomics | Nature Communications
